Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Obese human subjects have increased protein-tyrosine phosphatase (PTPase) activity in adipose tissue that can dephosphorylate and inactivate the insulin receptor kinase. To extend these findings to skeletal muscle, we measured PTPase activity in the skeletal muscle particulate fraction and cytosol from a series of lean controls, insulin-resistant obese (body mass index > 30) nondiabetic subjects, and obese individuals with non-insulin-dependent diabetes. PTPase activities in subcellular fractions from the nondiabetic obese subjects were increased to 140-170% of the level in lean controls (P < 0.05). In contrast, PTPase activity in both fractions from the obese subjects with non-insulin-dependent diabetes was significantly decreased to 39% of the level in controls (P < 0.05). By immunoblot analysis, leukocyte antigen related (LAR) and protein-tyrosine phosphatase 1B had the greatest increase (threefold) in the particulate fraction from obese, nondiabetic subjects, and immunodepletion of this fraction using an affinity-purified antibody directed at the cytoplasmic domain of leukocyte antigen related normalized the PTPase activity when compared to the activity from control subjects. These findings provide further support for negative regulation of insulin action by specific PTPases in the pathogenesis of insulin resistance in human obesity, while other regulatory mechanisms may be operative in the diabetic state.

[1]  B. Goldstein,et al.  Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. , 1997, Metabolism: clinical and experimental.

[2]  B. Goldstein,et al.  Functional Association between the Insulin Receptor and the Transmembrane Protein-tyrosine Phosphatase LAR in Intact Cells* , 1997, The Journal of Biological Chemistry.

[3]  B. Goldstein,et al.  Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells. , 1996, Cellular signalling.

[4]  Jerrold M. Olefsky,et al.  Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.

[5]  B. Goldstein,et al.  Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR. , 1996, Molecular endocrinology.

[6]  A. Ullrich,et al.  Selective Down-regulation of the Insulin Receptor Signal by Protein-tyrosine Phosphatases α and ε (*) , 1995, The Journal of Biological Chemistry.

[7]  J. Meyerovitch,et al.  Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*) , 1995, The Journal of Biological Chemistry.

[8]  J. Sredy,et al.  Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor. , 1995, Metabolism: clinical and experimental.

[9]  B. Goldstein,et al.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. , 1995, The Journal of clinical investigation.

[10]  B. Goldstein,et al.  Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. , 1995, The American journal of physiology.

[11]  F. Giorgino,et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. , 1995, The Journal of clinical investigation.

[12]  B. Goldstein,et al.  Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue. , 1995, Biochimica et biophysica acta.

[13]  B. Goldstein,et al.  Insulin Receptor Signaling Is Augmented by Antisense Inhibition of the Protein Tyrosine Phosphatase LAR (*) , 1995, The Journal of Biological Chemistry.

[14]  A. Saltiel,et al.  Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Kasuga,et al.  Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. , 1994, Molecular and cellular biology.

[16]  S. Shoelson,et al.  Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. , 1994, The Journal of biological chemistry.

[17]  A. Saltiel,et al.  Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. , 1994, The Journal of biological chemistry.

[18]  K. Sullivan,et al.  Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning. , 1994, Biochemical and biophysical research communications.

[19]  J. Friedman,et al.  Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. , 1994, Metabolism: clinical and experimental.

[20]  R. Henry,et al.  Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. , 1994, The Journal of clinical investigation.

[21]  C. Kahn,et al.  The insulin signaling system. , 1994, The Journal of biological chemistry.

[22]  J. Olefsky,et al.  Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I. , 1993, The Journal of biological chemistry.

[23]  A. Ullrich,et al.  Differential activities of protein tyrosine phosphatases in intact cells. , 1993, The Journal of biological chemistry.

[24]  T. Pawson,et al.  The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. , 1993, The Journal of biological chemistry.

[25]  E. Van Obberghen,et al.  Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. , 1993, Endocrinology.

[26]  B. Goldstein.  Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. , 1993, Receptor.

[27]  B. Neel,et al.  Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[28]  B. Goldstein,et al.  Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C. , 1992, Biochemical and biophysical research communications.

[29]  C. Kahn,et al.  Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells. , 1992, Biochemistry.

[30]  B. Goldstein,et al.  Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. , 1992, The Journal of biological chemistry.

[31]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[32]  B. Goldstein.  Protein‐Tyrosine phosphatases and the regulation of insulin action , 1992, Journal of cellular biochemistry.

[33]  J. Caro.  Clinical review 26: Insulin resistance in obese and nonobese man. , 1991, The Journal of clinical endocrinology and metabolism.

[34]  N. Tonks,et al.  Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. , 1991, Science.

[35]  C. Bogardus,et al.  Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans , 1991, Diabetes.

[36]  N. Tonks,et al.  Purification and assay of CD45: an integral membrane protein-tyrosine phosphatase. , 1991, Methods in enzymology.

[37]  P. D’Eustachio,et al.  Cloning and expression of a widely expressed receptor tyrosine phosphatase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Krebs,et al.  Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  P. Gruppuso,et al.  Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. , 1990, The Journal of clinical investigation.

[40]  B. Neel,et al.  Cloning of a cDNA for a major human protein-tyrosine-phosphatase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  E. Krebs,et al.  Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes , 1990, Molecular and cellular biology.

[42]  J. Dixon,et al.  Cloning and expression of a protein-tyrosine-phosphatase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Gruppuso,et al.  Dephosphorylation of Insulin and Epidermal Growth Factor Receptors in Normal and Alloxan Diabetic Rats , 1990 .

[44]  W. Pories,et al.  Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. , 1989, Diabetes/metabolism reviews.

[45]  C. Kahn,et al.  Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats. , 1989, The Journal of clinical investigation.

[46]  M. Streuli,et al.  A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen , 1988, Journal of Experimental Medicine.

[47]  G. Dohm,et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.

[48]  C. Kahn,et al.  Phosphorylation of the insulin receptor in cultured hepatoma cells and a solubilized system. , 1985, Methods in enzymology.

[49]  J. Olefsky,et al.  Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. , 1980, The Journal of clinical investigation.

[50]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[51]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[52]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[53]  D. Rabinowitz.  Some endocrine and metabolic aspects of obesity. , 1970, Annual review of medicine.